Medical Discovery NewsBridging the World of Medical Discovery and You

Recent Episodes

Making Antivirals

MP3 WAV

  • With COVID-19, we're hearing a lot about antivirals. Just what are they?

    Unlike antibiotics that kill bacteria, antivirals slow down the virus enough for the body's own immune system to eliminate it and any infected cells. Heroic efforts to treat HIV patients brought some of the first antivirals. While in nineteen-ninety, there were just five antiviral drugs, today there are one hundred.

    Antivirals attack several functions of a virus, which are non-living infectious particles that depend on a host cell to reproduce. The first HIV antiviral designed back in 1987 targeted a viral enzyme called reverse transcriptase or RT. RT copies the viral RNA genome into DNA that can integrate into a host cell's genome. The drug, AZT, was able to block that ability. A number of HIV antivirals have now been developed.

    Using this knowledge, scientists are now working around the clock on antivirals for the new corona virus, SARS CoV-two, from developing new drugs to testing existing drugs. One antiviral is hydroxycholoroquine which might curb viral entry into cells and Remdesivir may prevent the replication of the virus in cells.

    But do not take these drugs without talking with your doctor since none are cleared to treat this virus. An elderly couple took chloroquine phosphate for aquarium fish as a preventative, but both were hospitalized, and the husband died.

More Information

Strategies in the design of antiviral drugs
A decade ago, just five drugs were licensed for the treatment of viral infections. Since then, greater understanding of viral life cycles, prompted in particular by the need to combat human immunodeficiency virus, has resulted in the discovery and validation of several targets for therapeutic intervention...

Approved Antiviral Drugs over the Past 50 Years
Since the first antiviral drug, idoxuridine, was approved in 1963, 90 antiviral drugs categorized into 13 functional groups have been formally approved for the treatment of 9 human infectious diseases...

Antiretroviral Drug Discovery and Development
For more than three decades, NIAID has fostered and promoted development of antiretroviral therapies that have transformed HIV infection from an almost uniformly fatal infection into a manageable chronic condition...

Two individuals wearing headphones stand in a recording booth, speaking into microphones with a music stand holding printed pages between them.

 Medicine...

Medicine is constantly advancing – that is a great thing about life in the 21st century. But it doesn’t just happen. Dedicated biomedical scientists are making discoveries that translate into those new medical advances.

Biomedical science is broad, encompassing everything from social science to microbiology, biochemistry, epidemiology, to structural biology and bioinformatics to name just a few areas. And, it can involve basic fundamental biology, the use of AI and chemistry to clinical studies that evaluate new medicines in patients.

No matter the research focus, the goal is always the same, to advance human health. It may take a few months, a few years or for fundamental science, a few decades. Few people make the connection that biomedical science is medicine and that biomedical scientists are working today on the medicine of tomorrow. Our weekly 500-word newspaper columns and 2-minute radio shows and podcasts provide insights into a broad range of biomedical science topics.

Medical Discovery News is dedicated to explaining discoveries in biomedical research and their promise for the future of medicine.

Podcasts

Alternatively, you can copy and paste the following web address (URL) into iTunes as a new subscription:
https://www.medicaldiscoverynews.com/shows/audio/mdnews.rss

You can also search and subscribe to "Medical Discovery News" in the podcast section of iTunes.

The www.medicaldiscoverynews.com web site and Medical Discovery News radio program (Program) are made possible by The University of Texas Medical Branch at Galveston (UTMB)as a community service and are intended to advance UTMB's mission of providing scholarly teaching, innovative scientific investigation, and state-of-the-art patient care in a learning environment to better the health of society and its commitment to the discovery of new innovative biomedical and health services knowledge leading to increasingly effective and accessible health care for the citizens of Texas.

All information provided on the web site and in the Program is for informational purposes only and is not intended for use as diagnosis or treatment of a health problem or as a substitute for consulting a licensed medical professional. Any information obtained by participating as a web site visitor or program listener is not intended to and should not be considered to constitute medical advice.

Thoughts and opinions expressed on the Program or on the website are those of the authors or guests and do not necessarily reflect the opinions of UTMB. The provision of links to other websites is not to be construed as written or implied sponsorship or endorsement of such websites by UTMB.

Please contact Dr. David Niesel or Dr. Norbert Herzog via email with any concerns, suggestions or comments.

All rights are reserved to information provided on the website or other information sources. No part of these programs can be reproduced stored in a retrieval system or transcribed in any form or by any means for personal or financial gained without the express written permission of Drs. Niesel and Dr. Herzog.